Clinical aspects of genetic variability in Helicobacter pylori

JAMA

Volumn 283, Issue 10, 2000, Pages 1264-1266

  Spechler, Stuart Jon ^a   Fischbach, Lori ^b   Feldman, Mark ^b  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; CLINICAL FEATURE; GENETIC VARIABILITY; GRAM NEGATIVE BACTERIUM; HELICOBACTER PYLORI; PRIORITY JOURNAL; SHORT SURVEY; VIRULENCE;

EID: 0034008273     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.10.1264     Document Type: Short Survey

References (36)

1. Blaser MJ. Helicobacters are indigenous to the human stomach. Gut. 1998;43:721-727.
2. The EUROGAST Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut. 1993;34:1672-1676.
3. Scheiman JM, Cutler AF. Helicobacter pylori and gastric cancer. Am J Med. 1999;106:222-226.
4. Cover TL, Blaser MJ. Helicobacter pylori factors associated with disease. Gastroenterology. 1999;117: 257-260.
5. Blaser MJ. Not all Helicobacter pylori strains are created equal. Lancet. 1997;349:1020-1022.
6. Blaser MJ. Role of vacA and cagA locus of Helicobacter pylori in human disease. Aliment Pharmacol Ther. 1996;10(suppl 1):73-77.
7. Ching CK, Wong BC, Kwog E, Ong L, Covacci A, Lam SK. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol. 1996;91:949-953.
8. Go MF, Graham DY. Presence of the CagA gene in the majority of Helicobacter pylori strains is independent of whether the individual has duodenal ulcer or asymptomatic gastritis. Helicobacter. 1996;1: 107-111.
9. Park SM, Park J, Kim JG, Cho HD, Lee DH, Cha YJ. Infection with Helicobacter pylori expressing the cagA gene is not associated with an increased risk of developing peptic ulcer diseases in Korean patients. Scand J Gastroenterol. 1998;33:923-927.
10. Alm RA, Ling LSL, Moir DT, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 1999;397:176-180.
11. Kidd M, Lastovica AJ, Atherton JC, Louw JA. Heterogeneity in the Helicobacter pylori vacA and cagA genes. Gut. 1999;45:499-502.
12. Cover TL. Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Bio/ Chem. 1992;267:10570-10575.
13. Atherton JC. H pylori virulence factors. Br Med Bull. 1998;54:105-120.
14. Atherton JC. CagA, the cag pathogenicity island and Helicobacter pylori virulence. Gut. 1999;44:307-308.
15. Tummuru MKR, Cover TL, Blaser MJ. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun. 1994;62:2609-2613.
16. Graham DY, Yamaoka Y. H pylori and cagA. Helicobacter. 1998;3:145-151.
17. Wong BC, Lam SK, Ching CK, et al. Seroprevalence of cytotoxin-associated gene A positive Helicobacter pylori strains in Changle, an area with very high prevalence of gastric cancer in South China. Aliment Pharmacol Ther. 1999;13:1295-1302.
18. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to protein in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun. 1990;58:603-610.
19. Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specific Helicobacter pylori antigens. Am J Gastroenterol. 1996;91:1785-1788.
20. Holtmann G, Talley NJ, Mitchell H, Hazell S. Antibody response to specific H pylori antigens in functional dyspepsia, duodenal ulcer disease, and health. Am J Gastroenterol. 1998;93:1222-1227.
21. Hamlet A, Thoreson AC, Nilsson O, Svennerholm AN, Olbe L. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology. 1999;116:259-268.
22. Miehlke S, Kibler K, Kim JG, et al. Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol. 1996;91:1322-1325
23. Shyu RY, Jiang SY, Lai CH, Hsu CT, Young TH, Yeh MY. High frequency of cytotoxin-associated gene A in Helicobacter pylori isolated from asymptomatic subjects and peptic ulcer patients in Taiwan. J Clin Gasteroenterol. 1998;27:54-59.
24. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with cagA positive or cagA negative Helicobacter pylori infection. Gut. 1997;40:297-301.
25. Klaamas K, Held M, Wadstrom T, Lipping A, Kurtenkov O, IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer. 1996;67:1-5.
26. Kikuchi S, Crabtree JE, Forman D, et al. Association between infections with cagA-positive or cagA-negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Am J Gastroenterol. 1999;94:3455-3459.
27. Yamaoka Y, Kodama T, Kashima K, Graham DY. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol. 1999; 52:215-218.
28. Vorobjova T, Nilsson I, Kull K, et al. CagA protein seropositivity in a random sample of adult population and gastric cancer patients in Estonia. Eur J Gastroenterol Hepatol. 1998;10:41-46.
29. Rudi J, Kolb C, Maiwald M, et al. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci. 1997;42:1652-1659.
30. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995; 55:2111-2115.
31. Werdmuller BFM, Loffeld RJLF. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci. 1997;42:103-105.
32. Labenz J, Blum AL, Bayerdörffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 1997;112:1442-1447.
33. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of CagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 1998;115:50-57.
34. Hansson LE, Nyren O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335:242-249.
35. Peek RM Jr, Miller GG, Tham KT, et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest. 1995;71:760-770.
36. Van Doom LJ, Figueiredo C, Sanna R, et al. Clinical relevance of the cagA, vacA, and ice A status of Helicobacter pylori. Gastroenterology. 1998;115:58-66.